Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.160
+0.020 (1.75%)
Apr 2, 2026, 2:27 PM HKT

HKG:2348 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7441,8341,8321,5751,9932,502
Market Cap Growth
-4.81%0.10%16.32%-20.98%-20.34%18.77%
Enterprise Value
76682215031,0041,638
Last Close Price
1.161.221.120.901.071.25
PE Ratio
7.457.703.054.394.935.69
Forward PE
-8.598.598.598.598.59
PS Ratio
1.271.341.621.241.381.75
PB Ratio
0.460.490.520.500.670.85
P/TBV Ratio
0.550.570.590.580.771.00
P/FCF Ratio
--18.2910.307.6725.46
P/OCF Ratio
--7.824.224.065.19
EV/Sales Ratio
0.060.050.200.400.701.15
EV/EBITDA Ratio
0.210.190.691.291.853.08
EV/EBIT Ratio
0.300.271.031.652.123.51
EV/FCF Ratio
--2.213.293.8716.67
Debt / Equity Ratio
0.020.020.010.040.000.01
Debt / EBITDA Ratio
0.240.240.110.340.020.05
Debt / FCF Ratio
--0.370.870.040.29
Net Debt / Equity Ratio
-0.44-0.44-0.47-0.37-0.40-0.34
Net Debt / EBITDA Ratio
-4.57-4.57-5.19-2.97-2.24-1.86
Net Debt / FCF Ratio
---16.71-7.58-4.67-10.07
Asset Turnover
0.310.310.280.320.360.37
Inventory Turnover
2.572.572.032.312.302.18
Quick Ratio
3.733.733.382.241.591.72
Current Ratio
4.644.643.972.571.872.17
Return on Equity (ROE)
6.29%6.29%18.20%11.71%14.10%15.46%
Return on Assets (ROA)
3.55%3.55%3.31%4.73%7.47%7.62%
Return on Invested Capital (ROIC)
10.20%10.57%10.03%12.72%21.48%21.80%
Return on Capital Employed (ROCE)
6.50%6.50%5.80%9.30%15.30%14.40%
Earnings Yield
13.65%12.98%32.81%22.80%20.31%17.57%
FCF Yield
--5.47%9.71%13.04%3.93%
Dividend Yield
5.53%5.16%5.60%8.85%8.25%6.42%
Payout Ratio
--19.68%35.91%27.80%40.18%
Buyback Yield / Dilution
0.14%0.14%-0.22%-0.02%0.37%2.44%
Total Shareholder Return
5.97%5.30%5.38%8.83%8.62%8.85%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.